Clinical significance of urinary Monocyte Chemoattractant Protein-1 (uMCP-1) in Indian type 2 diabetic patients at different stages of diabetic nephropathy

International Journal of Diabetes Mellitus

Volumn 2, Issue 1, 2010, Pages 15-19

  Tilak, Priyanka ^a   Khashim, Zenith ^a   Kumpatla, Satyavani ^a   Babu, Mary ^a   Viswanathan, Vijay ^a  

^a MV Hospital for Diabetes   (India)

Author keywords

Diabetic nephropathy; India; Type 2 diabetes; Urinary MCP 1

Indexed keywords

CREATININE; MONOCYTE CHEMOTACTIC PROTEIN 1; UREA;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE URINE LEVEL; DETERIORATION; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INDIAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR;

EID: 77949327383     PISSN: 18775934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdm.2009.10.003     Document Type: Article

References (23)

1. Ritz E. Advances in nephrology: successes and lessons from diabetes mellitus. Nephrol Dial Transpl 16 Suppl. 7 (2001) 46-50
2. Parving H.H., Osterby R., and Ritz E. Diabetic nephropathy. In: Brenner B.M. (Ed). The kidney. 6th ed. (2000), W.B. Saunders Company, Philadelphia 1731-1773
3. Cooper M.E. Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet 352 (1998) 213-219
4. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Abe K., et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21 (1993) 480-485
5. Wada T., Furuichi K., Sakai N., Iwata Y., Yoshimoto K., Shimizu M., et al. Upregulation of MCP-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58 (2000) 1492-1498
6. Park I.S., Kiyomoto H., Abboud S.L., and Abboud H.E. Expression of transforming growth factor-β and type IV collagen in early streptozotocin induced diabetes. Diabetes 46 (1997) 473-480
7. Rovin B.H., and Phan L.T. Chemotactic factors and renal inflammation. Am J Kidney Dis 31 (1998) 1065-1084
8. Rovin B.H., Yoshiumura T., and Tan L. Cytokine induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148 (1992) 2148-2153
9. Rovin B.H., Rumancik M., Tan L., and Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71 (1994) 536-542
10. Oppenheim J.J., Zachariae Co.C., Mukaida N., and Matsushima K. Properties of the novel proinflammatory super gene "intercrine" cytokine family. Annu Rev Immunol 12 (1991) 503-633
11. Banba N., Nakamura T., Matsumura M., Kuroda H., Hattori Y., and Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58 (2000) 684-690
12. Rovin B.H., Doe N., and Tan L.C. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27 (1996) 640-646
13. Wang Q.-y., and Chen F.-q. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Diab Res Clin Prac 83 (2009) 215-219
14. Berthold A., Ralph T., and Bernhard A. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care 26 (2003) 2421-2425
15. Cockroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-34
16. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva
17. Stahl R.A.K., Thaiss F., Disser M., Helmchen U., Hora K., and Schlondorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 44 (1993) 1036-1047
18. Galkina E., and Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17 (2006) 368-377
19. Morri T., Fujita H., Narita T., Shimotomai T., Fujishima H., Yoshioka N., et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diab Compl 17 (2003) 11-15
20. Tashiro K., Koyanagi I., Saitoh A., Shimizu A., Shike T., Ishiguro C., et al. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 16 (2002) 1-4
21. Ibrahim S., and Rashed L. Correlation of urinary monocyte chemoattractant protein-1 with other parameters of renal injury in type 2 diabetes mellitus. Saudi J Kid Dis Transpl 19 (2008) 911-917
22. Francesco C., Angelika M., Matteo M., Annalisa I., Maria F., Stefano T., et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 25 (2002) 1829-1834
23. Bakker A.J. Detection of microalbuminuria. Diabetes Care 22 (1999) 307-313